Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In humans, loss-of-function mutations in multiple component genes of transforming growth factor (TGF)-β signaling have been demonstrated to cause proximal aortic aneurysms. However, association of human variants in the prototype ligand TGFB1 with thoracic aortic aneurysms have not been reported to date. To delineate the consequences of genetically altered Tgfb1 expression on aortic phenotype in mammals, we studied aortic phenotype in mice with loss-of-functions or gain-of-function mutations in Tgfb1 (Tgfb1 and Tgfb1). Tgfb1 mice spontaneously developed proximal aortic aneurysms and had markedly shortened lifespans as compared with wildtype, whereas Tgfb1mice did not develop aortic aneurysms and had comparable lifespans with wildtype. Aortic levels of collagen and elastin stable crosslinks, and the expression of their associated enzymes in Tgfb1 mice were significantly less than those in wildtype. These results suggest that TGF-β1 is protective against aortic aneurysms at least partly via increasing the cross-linking of collagen and elastin.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12162004PMC
http://dx.doi.org/10.1016/j.jphyss.2025.100024DOI Listing

Publication Analysis

Top Keywords

aortic aneurysms
24
proximal aortic
12
tgfb1 tgfb1
12
transforming growth
8
aortic
8
aortic phenotype
8
tgfb1 mice
8
collagen elastin
8
tgfb1
7
aneurysms
6

Similar Publications

Targeting USP21 to inhibit abdominal aortic aneurysm progression by suppressing the phenotypic transition of vascular smooth muscle cells.

Cell Rep Med

September 2025

Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan 250012, China; Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, Institute of Emergency and Critical Care Medicine of Shandong University, Chest Pain Center, Qilu Hospital of Shandong U

Abdominal aortic aneurysm (AAA) is a life-threatening condition lacking effective treatment. We investigate the role of the deubiquitinating enzyme USP21 in AAA development. Proteomic analysis reveals significant upregulation of USP21 in murine and human abdominal aortic tissues.

View Article and Find Full Text PDF

Aim: To describe the percentage of abdominal aortic aneurysm (AAA) cases in the Maspalomas Basic Health Zone among males aged 65 to 75 years who are current or former smokers. Our secondary objectives were to define the distribution of known risk factors for AAA development in our sample and to facilitate early referral to the appropriate vascular surgery service. We also aim to describe the percentage of subaneurysm cases, offering ultrasound follow-up at our center.

View Article and Find Full Text PDF

[Ultrasound screening for abdominal aortic aneurysm (AAA) in primary care in a rural population].

Aten Primaria

September 2025

Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, España.

Objective: To assess the feasibility of implementing ultrasound screening for abdominal aortic aneurysm (AAA) in primary care by examining the prevalence of AAA and associated risk factors in northern Lleida, where no prior data exist and cases are detected opportunistically.

Design: Cross-sectional retrospective prevalence study derived from a pilot implementation of ultrasound AAA screening as a routine complementary test in six rural primary care centres over a 12-month period (March 2022 - March 2023).

Setting: Northern area of the province of Lleida, specifically the regions of Alt Urgell, Pallars Sobirà, Pallars Jussà and Alta Ribagorça.

View Article and Find Full Text PDF

Background: Regular imaging surveillance is guideline-recommended for the management of thoracic aortic aneurysm (TAA) but has not been well described in clinical practice. Here we evaluated the frequency of imaging procedures and associated outcomes, procedures, and healthcare costs in patients with TAA.

Methods: A retrospective cohort study of inpatient and professional claims for 28,459 Medicare beneficiaries age ≥65 years with a diagnosis of TAA between 2017 and 2019 was performed.

View Article and Find Full Text PDF